Filing Flows

Filing Flows › Elanco Animal Health (ELAN) › Stock forecast & fair value

Elanco Animal Health (ELAN) stock forecast and fair value

Elanco Animal Health (ELAN) trades at $25.96. 13 analysts' median price target is $30.00 (+16%), from $25.00 to $35.00. Across 11 valuation methods the middle fair value is $24.14 (-7%).

Price$25.96
Median target$30.00
Fair value, middle$24.14
EPS beat rate100%
Elanco Animal Health fair value by method (price $25.96)Elanco Animal Health fair value by method (price $25.96)low – highpoint estimateEV/Sales vs peers$34.20EV/Sales vs peers, weighted$50.05EV/Sales vs peers, matched$34.46Residual income$8.09Analysts' price targets$30.69Owner earnings capitalized$10.58Path-to-margin DCF$18.69Path-to-margin DCF, dilution-adjust…$18.69Exit-multiple (venture) method$20.90Stage-weighted value (pre-profit / …$24.14

Fair value by method

MethodLowPointHighvs price
EV/Sales vs peers$17.30$34.20$74.51+32%
EV/Sales vs peers, weighted$27.68$50.05$81.90+93%
EV/Sales vs peers, matched$19.08$34.46$68.70+33%
Residual income$7.79$8.09$8.40-69%
Analysts' price targets$25.00$30.69$35.00+18%
Owner earnings capitalized$9.17$10.58$12.50-59%
Path-to-margin DCF$11.30$18.69$26.04-28%
Path-to-margin DCF, dilution-adjusted$11.30$18.69$26.04-28%
Exit-multiple (venture) method$12.54$20.90$42.41-19%
Stage-weighted value (pre-profit / high growth)$13.52$24.14$45.99-7%

Elanco Animal Health's latest quarter

Elanco Animal Health, Q3 2026: revenue $1.3B (+11% year over year), operating margin 1.9%, net earnings $18.0M, operating cash flow $216M. The chart follows the revenue to costs, profit and cash.

Questions

What is the price target for ELAN stock?

The median of 13 analysts' 12-month targets is $30.00, +16% from $25.96; the range is $25.00 to $35.00. The average rating is buy.

What is Elanco Animal Health's fair value?

The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $8.09 and $50.05, with a middle value of $24.14 against a price of $25.96. Each method's assumptions are on the page.

Does Elanco Animal Health usually beat earnings estimates?

It beat the consensus EPS estimate in 100% of the quarters on record.

Is ELAN stock a buy?

Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.